Literature DB >> 6976896

The toleration of rat thymocytes to xenogeneic erythrocytes: kinetics of induction and recovery.

J V Bunce, D W Mason.   

Abstract

The intravenous injection of large doses of xenogeneic erythrocytes into rats completely abrogated the ability of thymocytes from such animals to provide help for antierythrocyte antibody responses in an adoptive transfer system. Thymocyte tolerance developed at a time when the thymocyte donors were producing antibody to the tolerizing antigen, and spleen helper T cells were not tolerized by the injection protocol. A minimum of two injections of 1 ml of packed erythrocytes, spaced 4 - 5 days apart, was required to induce loss of helper activity. Tolerance was fully developed within 16 h of the last injection of antigen. Helper activity recovered over a 24-h period starting 5 days after this injection but could be delayed by giving further injections of antigen. These results suggest that the intrathymic pool of cells with assayable helper activity turns over in about one day and that precursors of this pool are probably also tolerable. Suppressor cells could not be detected in tolerant thymocyte populations indicating that the loss of helper activity was either a consequence of clonal inactivation or that an antigen-specific mechanism existed for the recruitment of helper cells from the thymus. The significance of these findings to the acquisition of self-tolerance is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6976896     DOI: 10.1002/eji.1830111108

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Functional clonal deletion of cytotoxic T-lymphocyte precursors in chimeric thymus produced in vitro from embryonic Anlagen.

Authors:  M F Good; K W Pyke; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

2.  The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients.

Authors:  A Saoudi; B Seddon; D Fowell; D Mason
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

3.  The MRC OX-44 antigen marks a functionally relevant subset among rat thymocytes.

Authors:  D J Paterson; J R Green; W A Jefferies; M Puklavec; A F Williams
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

4.  An intermediate cell in thymocyte differentiation that expresses CD8 but not CD4 antigen.

Authors:  D J Paterson; A F Williams
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

5.  MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen.

Authors:  G P Spickett; M R Brandon; D W Mason; A F Williams; G R Woollett
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.